Pfizer (PFE) Gains Despite U.K. Court Ruling

Pfizer Inc.

shares improved 0.7% to $32.85, after a U.K. judge ruled against the drug maker in a patent case involving its blockbuster drug Lyrica, leaving generic-drug makers free to sell cheap copycats. Share volume was 2.2 million, compared to an all-day average of 7.1 million